BioPharm International, July 2023

Manufacturers face the challenge of meeting growing demand for personalized biopharmaceuticals.

Use of a small-scale filler can result in increased filling efficiency.

Despite many development challenges, stable producer cell lines show real promise.

CPC presents a green alternative to chromatography that supports sustainable operations.

Experts outline the benefits of single-use consumables relative to traditional approaches.

Considering the differences between small- and large-molecule drug products can help determine analytical testing methods for E&L.

Problems continue despite actions by regulators to better prevent and address drug shortages.

FDA Warning Letters and Form 483s can offer a path to better compliance, says Siegfried Schmitt, vice president, Technical, at Parexel.

If we view a change opposite of one’s interest as antithetical to innovation, we risk losing sight of our ultimate goal.

The debate surrounding drug pricing changes rages on.